Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2850156 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNACYP3A4HSD17B10MAPT | |
| SCHEMBL10798965 | 0.86 | ALDH1A1 (0.53) | ALDH1A1LMNACYP3A4HSD17B10TSHR | |
| SCHEMBL13321344 | 0.86 | ALDH1A1 (0.49) | ALDH1A1LMNACYP3A4HSD17B10TSHR | |
| SCHEMBL2601871 | 0.86 | LMNA (0.58) | ALDH1A1LMNACYP3A4HSD17B10MAPT | |
| SCHEMBL5471637 | 0.86 | PLA2G4B (0.60) | ALDH1A1LMNACYP3A4HSD17B10TSHR | |
| SCHEMBL15890908 | 0.86 | ALDH1A1 (0.73) | ALDH1A1LMNACYP3A4HSD17B10MAPT | |
| SCHEMBL12112442 | 0.84 | TSHR (0.56) | ALDH1A1LMNAMAPTTSHRGAA | |
| SCHEMBL4653601 | 0.84 | PARP10 (0.55) | ALDH1A1LMNACYP3A4HSD17B10TSHR | |
| SCHEMBL5472176 | 0.84 | ALDH1A1 (0.50) | ALDH1A1LMNACYP3A4HSD17B10MAPT | |
| SCHEMBL12606083 | 0.84 | ALDH1A1 (0.51) | ALDH1A1LMNACYP3A4HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501037-B2 | Optically anisotropic compound and resin composition comprising the same | LG CHEM, LTD. (KR) | 2013-08-06 | — | — | US | disclosed |
| US-8501037-B2 | Optically anisotropic compound and resin composition comprising the same | LG CHEM, LTD. (KR) | 2013-08-06 | — | — | US | disclosed |
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
| WO-2009025484-A2 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2009-02-26 | — | — | WO | disclosed |
| US-20070282042-A1 | Esters of anhydrosugar alcohols as plasticizers | UNITED STATE DEPARTMENT OF ENERGY | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | RCC1, RER1, MED1 | ALDH1A1 1619/4885LMNA 2515/4885CYP3A4 1976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.